{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-079392","form_type":"8-K","ticker":"TMDX","cik":"0001756262","company_name":"TransMedics Group, Inc.","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.085550+00:00","generated_at":"2026-05-15T23:08:49.950127+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"TransMedics provides tax valuation allowance impact: Q4 adjusted EPS $0.47","bullets":["Released $103.3M U.S. tax valuation allowance in Q4, driving $83.8M net income tax benefit.","Annual effective tax rate 2025 was (77.0)%; without allowance release it would have been 19.1%.","Q4 pre-tax income $21.6M; reported net income $105.4M ($2.62 diluted EPS).","Adjusted net income after 19.1% tax rate: $17.5M ($0.47 diluted EPS).","Future quarters expected to have tax provision more in line with U.S. statutory rates."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-079392","json":"https://secwatch.observer/filing/0001193125-26-079392.json","markdown":"https://secwatch.observer/filing/0001193125-26-079392.md","text":"https://secwatch.observer/filing/0001193125-26-079392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756262/000119312526079392/0001193125-26-079392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756262/000119312526079392/d80286d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:08:49.950127+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}